-
1
-
-
84938125365
-
An official ATS/ERS/JRS/ALAT Clinical practice guideline: treatment of idiopathic pulmonary fibrosis. an update of the 2011 clinical practice guideline
-
1 Raghu, G, Rochwerg, B, Zhang, Y, et al. An official ATS/ERS/JRS/ALAT Clinical practice guideline: treatment of idiopathic pulmonary fibrosis. an update of the 2011 clinical practice guideline. Am J Respir Crit Care Med 192 (2015), e3–19.
-
(2015)
Am J Respir Crit Care Med
, vol.192
, pp. e3-19
-
-
Raghu, G.1
Rochwerg, B.2
Zhang, Y.3
-
2
-
-
84861394764
-
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis
-
2 Idiopathic Pulmonary Fibrosis Clinical Research Network, Raghu, G, Anstrom, KJ, King, TE Jr, Lasky, JA, Martinez, FJ, Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 366 (2012), 1968–1977.
-
(2012)
N Engl J Med
, vol.366
, pp. 1968-1977
-
-
Raghu, G.1
Anstrom, K.J.2
King, T.E.3
Lasky, J.A.4
Martinez, F.J.5
-
3
-
-
84901746607
-
Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis
-
3 Martinez, FJ, de Andrade, JA, Anstrom, KJ, King, TE Jr, Raghu, G, Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 370 (2014), 2093–2101.
-
(2014)
N Engl J Med
, vol.370
, pp. 2093-2101
-
-
Martinez, F.J.1
de Andrade, J.A.2
Anstrom, K.J.3
King, T.E.4
Raghu, G.5
-
4
-
-
84965062194
-
Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial
-
4 Behr, J, Bendstrup, E, Crestani, B, et al. Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Respir Med 4 (2016), 445–453.
-
(2016)
Lancet Respir Med
, vol.4
, pp. 445-453
-
-
Behr, J.1
Bendstrup, E.2
Crestani, B.3
-
5
-
-
84964057055
-
Idiopathic pulmonary fibrosis: securing a confident diagnosis for every patient
-
5 Jones, MG, Walsh, SLF, Jones, KD, Richeldi, L, Idiopathic pulmonary fibrosis: securing a confident diagnosis for every patient. Eur Respir J 47 (2016), 1057–1059.
-
(2016)
Eur Respir J
, vol.47
, pp. 1057-1059
-
-
Jones, M.G.1
Walsh, S.L.F.2
Jones, K.D.3
Richeldi, L.4
-
6
-
-
84981225532
-
Counterpoint: should all patients with idiopathic pulmonary fibrosis, even those with more than moderate impairment, be treated with nintedanib or pirfenidone? No
-
6 Brown, KK, Counterpoint: should all patients with idiopathic pulmonary fibrosis, even those with more than moderate impairment, be treated with nintedanib or pirfenidone? No. Chest 150 (2016), 276–278.
-
(2016)
Chest
, vol.150
, pp. 276-278
-
-
Brown, K.K.1
-
7
-
-
84988884607
-
Precision medicine: the new frontier in idiopathic pulmonary fibrosis
-
7 Brownell, R, Kaminski, N, Woodruff, PG, et al. Precision medicine: the new frontier in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 193 (2016), 1213–1218.
-
(2016)
Am J Respir Crit Care Med
, vol.193
, pp. 1213-1218
-
-
Brownell, R.1
Kaminski, N.2
Woodruff, P.G.3
-
8
-
-
84959251562
-
Novel drug targets for idiopathic pulmonary fibrosis
-
published online Feb 26.
-
8 Sgalla, G, Cocconcelli, E, Tonelli, R, Richeldi, L, Novel drug targets for idiopathic pulmonary fibrosis. Expert Rev Respir Med, 2016, 10.1586/17476348.2016.1152186 published online Feb 26.
-
(2016)
Expert Rev Respir Med
-
-
Sgalla, G.1
Cocconcelli, E.2
Tonelli, R.3
Richeldi, L.4
-
9
-
-
33749444308
-
Incidence and prevalence of idiopathic pulmonary fibrosis
-
9 Raghu, G, Weycker, D, Edelsberg, J, Bradford, WZ, Oster, G, Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 174 (2006), 810–816.
-
(2006)
Am J Respir Crit Care Med
, vol.174
, pp. 810-816
-
-
Raghu, G.1
Weycker, D.2
Edelsberg, J.3
Bradford, W.Z.4
Oster, G.5
-
10
-
-
84901022861
-
Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. An integral model
-
10 Selman, M, Pardo, A, Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. An integral model. Am J Respir Crit Care Med 189 (2014), 1161–1172.
-
(2014)
Am J Respir Crit Care Med
, vol.189
, pp. 1161-1172
-
-
Selman, M.1
Pardo, A.2
-
11
-
-
77953077453
-
Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis
-
11 Fell, CD, Martinez, FJ, Liu, LX, et al. Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 181 (2010), 832–837.
-
(2010)
Am J Respir Crit Care Med
, vol.181
, pp. 832-837
-
-
Fell, C.D.1
Martinez, F.J.2
Liu, L.X.3
-
12
-
-
84984807297
-
Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: a cross sectional analysis of ILD patients undergoing lung tissue sampling
-
12 Salisbury, ML, Xia, M, Murray, S, et al. Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: a cross sectional analysis of ILD patients undergoing lung tissue sampling. Respir Med 118 (2016), 88–95.
-
(2016)
Respir Med
, vol.118
, pp. 88-95
-
-
Salisbury, M.L.1
Xia, M.2
Murray, S.3
-
13
-
-
37349123498
-
Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT
-
13 Silva, CI, Muller, NL, Lynch, DA, et al. Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology 246 (2008), 288–297.
-
(2008)
Radiology
, vol.246
, pp. 288-297
-
-
Silva, C.I.1
Muller, N.L.2
Lynch, D.A.3
-
14
-
-
73349104430
-
Pathologic patterns and survival in chronic hypersensitivity pneumonitis
-
14 Churg, A, Sin, DD, Everett, D, Brown, K, Cool, C, Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am J Surg Pathol 33 (2009), 1765–1770.
-
(2009)
Am J Surg Pathol
, vol.33
, pp. 1765-1770
-
-
Churg, A.1
Sin, D.D.2
Everett, D.3
Brown, K.4
Cool, C.5
-
15
-
-
84887051071
-
Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study
-
15 Morell, F, Villar, A, Montero, MA, et al. Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study. Lancet Respir Med 1 (2013), 685–694.
-
(2013)
Lancet Respir Med
, vol.1
, pp. 685-694
-
-
Morell, F.1
Villar, A.2
Montero, M.A.3
-
16
-
-
84942925433
-
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features
-
16 Fischer, A, Antoniou, KM, Brown, KK, et al. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 46 (2015), 976–987.
-
(2015)
Eur Respir J
, vol.46
, pp. 976-987
-
-
Fischer, A.1
Antoniou, K.M.2
Brown, K.K.3
-
17
-
-
84907333644
-
Smoking-related idiopathic interstitial pneumonia
-
17 Flaherty, KR, Fell, C, Aubry, MC, et al. Smoking-related idiopathic interstitial pneumonia. Eur Respir J 44 (2014), 594–602.
-
(2014)
Eur Respir J
, vol.44
, pp. 594-602
-
-
Flaherty, K.R.1
Fell, C.2
Aubry, M.C.3
-
18
-
-
84966474593
-
Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case cohort study
-
18 Walsh, SLF, Wells, AU, Desai, SR, et al. Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case cohort study. Lancet Respir Med 4 (2016), 557–565.
-
(2016)
Lancet Respir Med
, vol.4
, pp. 557-565
-
-
Walsh, S.L.F.1
Wells, A.U.2
Desai, S.R.3
-
19
-
-
84971275439
-
Hypersensitivity pneumonitis: challenges in diagnosis and management, avoiding surgical lung biopsy
-
19 Morell, F, Villar, A, Ojanguren, I, Munoz, X, Cruz, MJ, Hypersensitivity pneumonitis: challenges in diagnosis and management, avoiding surgical lung biopsy. Semin Respir Crit Care Med 37 (2016), 395–405.
-
(2016)
Semin Respir Crit Care Med
, vol.37
, pp. 395-405
-
-
Morell, F.1
Villar, A.2
Ojanguren, I.3
Munoz, X.4
Cruz, M.J.5
-
20
-
-
79952717349
-
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management
-
20 Raghu, G, Collard, HR, Egan, JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183 (2011), 788–824.
-
(2011)
Am J Respir Crit Care Med
, vol.183
, pp. 788-824
-
-
Raghu, G.1
Collard, H.R.2
Egan, J.J.3
-
21
-
-
84867094057
-
Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study
-
21 Nielsen, SF, Bojesen, SE, Schnohr, P, Nordestgaard, BG, Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study. BMJ, 345, 2012, e5244.
-
(2012)
BMJ
, vol.345
, pp. e5244
-
-
Nielsen, S.F.1
Bojesen, S.E.2
Schnohr, P.3
Nordestgaard, B.G.4
-
22
-
-
0003940848
-
-
13th edn. Springer New York New York
-
22 Klippel, JH, Stone, JH, Crofford, LJ, White, PH, (eds.) Chapter 2. Primer on the rheumatic diseases, 13th edn., 2008, Springer New York, New York, 15–20.
-
(2008)
Chapter 2. Primer on the rheumatic diseases
, pp. 15-20
-
-
Klippel, J.H.1
Stone, J.H.2
Crofford, L.J.3
White, P.H.4
-
23
-
-
0025364239
-
Autoantibodies of systemic rheumatic diseases in the healthy elderly
-
23 Ruffatti, A, Rossi, L, Calligaro, A, et al. Autoantibodies of systemic rheumatic diseases in the healthy elderly. Gerontology 36 (1990), 104–111.
-
(1990)
Gerontology
, vol.36
, pp. 104-111
-
-
Ruffatti, A.1
Rossi, L.2
Calligaro, A.3
-
24
-
-
84872107180
-
Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis
-
24 Lee, JS, Kim, EJ, Lynch, KL, et al. Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis. Respir Med 107 (2013), 249–255.
-
(2013)
Respir Med
, vol.107
, pp. 249-255
-
-
Lee, J.S.1
Kim, E.J.2
Lynch, K.L.3
-
25
-
-
84964010222
-
Interstitial pneumonia with autoimmune features: the new consensus-based definition for this cohort of patients should be broadened
-
25 Collins, B, Raghu, G, Interstitial pneumonia with autoimmune features: the new consensus-based definition for this cohort of patients should be broadened. Eur Respir J 47 (2016), 1293–1295.
-
(2016)
Eur Respir J
, vol.47
, pp. 1293-1295
-
-
Collins, B.1
Raghu, G.2
-
26
-
-
84865295963
-
Hypersensitivity pneumonitis: insights in diagnosis and pathobiology
-
26 Selman, M, Pardo, A, King, TE Jr, Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. Am J Respir Crit Care Med 186 (2012), 314–324.
-
(2012)
Am J Respir Crit Care Med
, vol.186
, pp. 314-324
-
-
Selman, M.1
Pardo, A.2
King, T.E.3
-
27
-
-
84960080689
-
Hypersensitivity pneumonitis and antigen identification—an alternate approach
-
27 Millerick-May, ML, Mulks, MH, Gerlach, J, et al. Hypersensitivity pneumonitis and antigen identification—an alternate approach. Respir Med 112 (2016), 97–105.
-
(2016)
Respir Med
, vol.112
, pp. 97-105
-
-
Millerick-May, M.L.1
Mulks, M.H.2
Gerlach, J.3
-
28
-
-
84860621394
-
An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease
-
28 Meyer, KC, Raghu, G, Baughman, RP, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 185 (2012), 1004–1014.
-
(2012)
Am J Respir Crit Care Med
, vol.185
, pp. 1004-1014
-
-
Meyer, K.C.1
Raghu, G.2
Baughman, R.P.3
-
29
-
-
84916207141
-
Diagnostic yield of specific inhalation challenge in hypersensitivity pneumonitis
-
29 Munoz, X, Sanchez-Ortiz, M, Torres, F, Villar, A, Morell, F, Cruz, MJ, Diagnostic yield of specific inhalation challenge in hypersensitivity pneumonitis. Eur Respir J 44 (2014), 1658–1665.
-
(2014)
Eur Respir J
, vol.44
, pp. 1658-1665
-
-
Munoz, X.1
Sanchez-Ortiz, M.2
Torres, F.3
Villar, A.4
Morell, F.5
Cruz, M.J.6
-
30
-
-
80053091084
-
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis
-
30 Richeldi, L, Costabel, U, Selman, M, et al. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med 365 (2011), 1079–1087.
-
(2011)
N Engl J Med
, vol.365
, pp. 1079-1087
-
-
Richeldi, L.1
Costabel, U.2
Selman, M.3
-
31
-
-
84879323836
-
UIP diagnosed at surgical lung biopsy, 2000–2009: HRCT patterns and proposed classification system
-
31 Gruden, JF, Panse, PM, Leslie, KO, Tazelaar, HD, Colby, TV, UIP diagnosed at surgical lung biopsy, 2000–2009: HRCT patterns and proposed classification system. AJR Am J Roentgenol 200 (2013), W458–W467.
-
(2013)
AJR Am J Roentgenol
, vol.200
, pp. W458-W467
-
-
Gruden, J.F.1
Panse, P.M.2
Leslie, K.O.3
Tazelaar, H.D.4
Colby, T.V.5
-
32
-
-
84897957320
-
Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial
-
32 Raghu, G, Lynch, D, Godwin, JD, et al. Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial. Lancet Respir Med 2 (2014), 277–284.
-
(2014)
Lancet Respir Med
, vol.2
, pp. 277-284
-
-
Raghu, G.1
Lynch, D.2
Godwin, J.D.3
-
33
-
-
84923857384
-
CT scan findings of probable usual interstitial pneumonitis have a high predictive value for histologic usual interstitial pneumonitis
-
33 Chung, JH, Chawla, A, Peljto, AL, et al. CT scan findings of probable usual interstitial pneumonitis have a high predictive value for histologic usual interstitial pneumonitis. Chest 147 (2015), 450–459.
-
(2015)
Chest
, vol.147
, pp. 450-459
-
-
Chung, J.H.1
Chawla, A.2
Peljto, A.L.3
-
34
-
-
84901810710
-
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis
-
34 Richeldi, L, du Bois, RM, Raghu, G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 370 (2014), 2071–2082.
-
(2014)
N Engl J Med
, vol.370
, pp. 2071-2082
-
-
Richeldi, L.1
du Bois, R.M.2
Raghu, G.3
-
35
-
-
84895446095
-
Neglected evidence in idiopathic pulmonary fibrosis and the importance of early diagnosis and treatment
-
35 Cottin, V, Richeldi, L, Neglected evidence in idiopathic pulmonary fibrosis and the importance of early diagnosis and treatment. Eur Respir Rev 23 (2014), 106–110.
-
(2014)
Eur Respir Rev
, vol.23
, pp. 106-110
-
-
Cottin, V.1
Richeldi, L.2
-
36
-
-
85008698220
-
Effect of nintedanib in subgroups of idiopathic pulmonary fibrosis by diagnostic criteria
-
published online June 22.
-
36 Raghu, G, Wells, AU, Nicholson, AG, et al. Effect of nintedanib in subgroups of idiopathic pulmonary fibrosis by diagnostic criteria. Am J Respir Crit Care Med, 2016, 10.1164/rccm.201602-0402OC published online June 22.
-
(2016)
Am J Respir Crit Care Med
-
-
Raghu, G.1
Wells, A.U.2
Nicholson, A.G.3
-
37
-
-
84880690413
-
Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate
-
37 Jin, GY, Lynch, D, Chawla, A, et al. Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate. Radiology 268 (2013), 563–571.
-
(2013)
Radiology
, vol.268
, pp. 563-571
-
-
Jin, G.Y.1
Lynch, D.2
Chawla, A.3
-
38
-
-
84958719073
-
Association between interstitial lung abnormalities and all-cause mortality
-
38 Putman, RK, Hatabu, H, Araki, T, et al. Association between interstitial lung abnormalities and all-cause mortality. JAMA 315 (2016), 672–681.
-
(2016)
JAMA
, vol.315
, pp. 672-681
-
-
Putman, R.K.1
Hatabu, H.2
Araki, T.3
-
39
-
-
85007436470
-
Development and progression of interstitial lung abnormalities in the Framingham Heart Study
-
published online June 17.
-
39 Akari, T, Putman, RK, Hatabu, H, et al. Development and progression of interstitial lung abnormalities in the Framingham Heart Study. Am J Respir Crit Care Med, 2016, 10.1164/rccm.201512-2523OC published online June 17.
-
(2016)
Am J Respir Crit Care Med
-
-
Akari, T.1
Putman, R.K.2
Hatabu, H.3
-
40
-
-
0002572171
-
Epidemiological approaches to heart disease: the Framingham Study
-
40 Dawber, TR, Meadors, GF, Moore, FE Jr, Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health 41 (1951), 279–281.
-
(1951)
Am J Public Health Nations Health
, vol.41
, pp. 279-281
-
-
Dawber, T.R.1
Meadors, G.F.2
Moore, F.E.3
-
41
-
-
34247126863
-
Age, Gene/Environment Susceptibility–Reykjavik Study: multidisciplinary applied phenomics
-
41 Harris, TB, Launer, LJ, Eiriksdottir, G, et al. Age, Gene/Environment Susceptibility–Reykjavik Study: multidisciplinary applied phenomics. Am J Epidemiol 165 (2007), 1076–1087.
-
(2007)
Am J Epidemiol
, vol.165
, pp. 1076-1087
-
-
Harris, T.B.1
Launer, L.J.2
Eiriksdottir, G.3
-
42
-
-
77949363490
-
Genetic epidemiology of COPD (COPDGene) study design
-
42 Regan, EA, Hokanson, JE, Murphy, JR, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD 7 (2010), 32–43.
-
(2010)
COPD
, vol.7
, pp. 32-43
-
-
Regan, E.A.1
Hokanson, J.E.2
Murphy, J.R.3
-
43
-
-
42949146028
-
Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE)
-
43 Vestbo, J, Anderson, W, Coxson, HO, et al., on behalf of the ECLIPSE investigators. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J 31 (2008), 869–873.
-
(2008)
Eur Respir J
, vol.31
, pp. 869-873
-
-
Vestbo, J.1
Anderson, W.2
Coxson, H.O.3
-
44
-
-
84957917892
-
Interobserver agreement for the ATS/ERS/JRS/ALAT criteria for a UIP pattern on CT
-
44 Walsh, SL, Calandriello, L, Sverzellati, N, Wells, AU, Hansell, DM, Consort, UIPO, Interobserver agreement for the ATS/ERS/JRS/ALAT criteria for a UIP pattern on CT. Thorax 71 (2016), 45–51.
-
(2016)
Thorax
, vol.71
, pp. 45-51
-
-
Walsh, S.L.1
Calandriello, L.2
Sverzellati, N.3
Wells, A.U.4
Hansell, D.M.5
Consort, U.I.P.O.6
-
45
-
-
84874338694
-
Interobserver variability in the CT assessment of honeycombing in the lungs
-
45 Watadani, T, Sakai, F, Johkoh, T, et al. Interobserver variability in the CT assessment of honeycombing in the lungs. Radiology 266 (2013), 936–944.
-
(2013)
Radiology
, vol.266
, pp. 936-944
-
-
Watadani, T.1
Sakai, F.2
Johkoh, T.3
-
46
-
-
84883051839
-
The revised ATS/ERS/JRS/ALAT diagnostic criteria for idiopathic pulmonary fibrosis (IPF)—practical implications
-
46 Wells, AU, The revised ATS/ERS/JRS/ALAT diagnostic criteria for idiopathic pulmonary fibrosis (IPF)—practical implications. Respir Res, 14(suppl 1), 2013, S2.
-
(2013)
Respir Res
, vol.14
, pp. S2
-
-
Wells, A.U.1
-
47
-
-
84979695447
-
In-hospital mortality after surgical lung biopsy for interstitial lung disease in the United States. 2000 to 2011
-
47 Hutchinson, JP, Fogarty, AW, McKeever, TM, Hubbard, RB, In-hospital mortality after surgical lung biopsy for interstitial lung disease in the United States. 2000 to 2011. Am J Respir Crit Care Med 193 (2016), 1161–1167.
-
(2016)
Am J Respir Crit Care Med
, vol.193
, pp. 1161-1167
-
-
Hutchinson, J.P.1
Fogarty, A.W.2
McKeever, T.M.3
Hubbard, R.B.4
-
48
-
-
84988966334
-
Acute exacerbation of idiopathic pulmonary fibrosis. an international working group report
-
48 Collard, HR, Ryerson, CJ, Corte, TJ, et al. Acute exacerbation of idiopathic pulmonary fibrosis. an international working group report. Am J Respir Crit Care Med 194 (2016), 265–275.
-
(2016)
Am J Respir Crit Care Med
, vol.194
, pp. 265-275
-
-
Collard, H.R.1
Ryerson, C.J.2
Corte, T.J.3
-
49
-
-
84881669432
-
An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias
-
49 Travis, WD, Costabel, U, Hansell, DM, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188 (2013), 733–748.
-
(2013)
Am J Respir Crit Care Med
, vol.188
, pp. 733-748
-
-
Travis, W.D.1
Costabel, U.2
Hansell, D.M.3
-
50
-
-
0033763063
-
A randomized, controlled trial comparing thoracoscopy and limited thoracotomy for lung biopsy in interstitial lung disease
-
50 Miller, JD, Urschel, JD, Cox, G, et al. A randomized, controlled trial comparing thoracoscopy and limited thoracotomy for lung biopsy in interstitial lung disease. Ann Thorac Surg 70 (2000), 1647–1650.
-
(2000)
Ann Thorac Surg
, vol.70
, pp. 1647-1650
-
-
Miller, J.D.1
Urschel, J.D.2
Cox, G.3
-
51
-
-
48949091397
-
Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases
-
51 Katzenstein, AL, Mukhopadhyay, S, Myers, JL, Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases. Hum Pathol 39 (2008), 1275–1294.
-
(2008)
Hum Pathol
, vol.39
, pp. 1275-1294
-
-
Katzenstein, A.L.1
Mukhopadhyay, S.2
Myers, J.L.3
-
52
-
-
0035508478
-
Histopathologic variability in usual and nonspecific interstitial pneumonias
-
52 Flaherty, KR, Travis, WD, Colby, TV, et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 164 (2001), 1722–1727.
-
(2001)
Am J Respir Crit Care Med
, vol.164
, pp. 1722-1727
-
-
Flaherty, K.R.1
Travis, W.D.2
Colby, T.V.3
-
53
-
-
33845982186
-
Organizing pneumonia and lymphoplasmacytic inflammation predict treatment response in idiopathic pulmonary fibrosis
-
53 Collard, HR, Cool, CD, Leslie, KO, Curran-Everett, D, Groshong, S, Brown, KK, Organizing pneumonia and lymphoplasmacytic inflammation predict treatment response in idiopathic pulmonary fibrosis. Histopathology 50 (2007), 258–265.
-
(2007)
Histopathology
, vol.50
, pp. 258-265
-
-
Collard, H.R.1
Cool, C.D.2
Leslie, K.O.3
Curran-Everett, D.4
Groshong, S.5
Brown, K.K.6
-
54
-
-
0038628915
-
Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease
-
54 Flaherty, KR, Colby, TV, Travis, WD, et al. Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med 167 (2003), 1410–1415.
-
(2003)
Am J Respir Crit Care Med
, vol.167
, pp. 1410-1415
-
-
Flaherty, K.R.1
Colby, T.V.2
Travis, W.D.3
-
55
-
-
0037099161
-
The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis
-
55 Nicholson, AG, Fulford, LG, Colby, TV, du Bois, RM, Hansell, DM, Wells, AU, The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 166 (2002), 173–177.
-
(2002)
Am J Respir Crit Care Med
, vol.166
, pp. 173-177
-
-
Nicholson, A.G.1
Fulford, L.G.2
Colby, T.V.3
du Bois, R.M.4
Hansell, D.M.5
Wells, A.U.6
-
56
-
-
0035883582
-
Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality
-
56 King, TE Jr, Schwarz, MI, Brown, K, et al. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med 164 (2001), 1025–1032.
-
(2001)
Am J Respir Crit Care Med
, vol.164
, pp. 1025-1032
-
-
King, T.E.1
Schwarz, M.I.2
Brown, K.3
-
57
-
-
43049110169
-
Profusion of fibroblast foci in patients with idiopathic pulmonary fibrosis does not predict outcome
-
57 Hanak, V, Ryu, JH, de Carvalho, E, et al. Profusion of fibroblast foci in patients with idiopathic pulmonary fibrosis does not predict outcome. Respir Med 102 (2008), 852–856.
-
(2008)
Respir Med
, vol.102
, pp. 852-856
-
-
Hanak, V.1
Ryu, J.H.2
de Carvalho, E.3
-
58
-
-
0036891960
-
Usual interstitial pneumonia: histologic study of biopsy and explant specimens
-
58 Katzenstein, AL, Zisman, DA, Litzky, LA, Nguyen, BT, Kotloff, RM, Usual interstitial pneumonia: histologic study of biopsy and explant specimens. Am J Surg Pathol 26 (2002), 1567–1577.
-
(2002)
Am J Surg Pathol
, vol.26
, pp. 1567-1577
-
-
Katzenstein, A.L.1
Zisman, D.A.2
Litzky, L.A.3
Nguyen, B.T.4
Kotloff, R.M.5
-
59
-
-
66249145452
-
Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis
-
59 Ohshimo, S, Bonella, F, Cui, A, et al. Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179 (2009), 1043–1047.
-
(2009)
Am J Respir Crit Care Med
, vol.179
, pp. 1043-1047
-
-
Ohshimo, S.1
Bonella, F.2
Cui, A.3
-
60
-
-
33847664321
-
Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease
-
60 Leslie, KO, Gruden, JF, Parish, JM, Scholand, MB, Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease. Arch Pathol Lab Med 131 (2007), 407–423.
-
(2007)
Arch Pathol Lab Med
, vol.131
, pp. 407-423
-
-
Leslie, K.O.1
Gruden, J.F.2
Parish, J.M.3
Scholand, M.B.4
-
61
-
-
33646468631
-
Transbronchial biopsy in usual interstitial pneumonia
-
61 Berbescu, EA, Katzenstein, AL, Snow, JL, Zisman, DA, Transbronchial biopsy in usual interstitial pneumonia. Chest 129 (2006), 1126–1131.
-
(2006)
Chest
, vol.129
, pp. 1126-1131
-
-
Berbescu, E.A.1
Katzenstein, A.L.2
Snow, J.L.3
Zisman, D.A.4
-
62
-
-
77951918393
-
Histopathologic findings of transbronchial biopsy in usual interstitial pneumonia
-
62 Shim, HS, Park, MS, Park, IK, Histopathologic findings of transbronchial biopsy in usual interstitial pneumonia. Pathol Int 60 (2010), 373–377.
-
(2010)
Pathol Int
, vol.60
, pp. 373-377
-
-
Shim, H.S.1
Park, M.S.2
Park, I.K.3
-
63
-
-
84930871576
-
Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high-dimensional transcriptional data
-
63 Kim, SY, Diggans, J, Pankratz, D, et al. Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high-dimensional transcriptional data. Lancet Respir Med 3 (2015), 473–482.
-
(2015)
Lancet Respir Med
, vol.3
, pp. 473-482
-
-
Kim, S.Y.1
Diggans, J.2
Pankratz, D.3
-
64
-
-
85020374483
-
Use of transbronchial cryobiopsy in the diagnosis of interstitial lung disease—a systematic review and cost analysis
-
published online Aug 13.
-
64 Sharp, C, McCabe, M, Adamali, H, Medford, AR, Use of transbronchial cryobiopsy in the diagnosis of interstitial lung disease—a systematic review and cost analysis. QJM, 2016, 10.1093/qjmed/hcw142 published online Aug 13.
-
(2016)
QJM
-
-
Sharp, C.1
McCabe, M.2
Adamali, H.3
Medford, A.R.4
-
65
-
-
84896514009
-
Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases
-
65 Casoni, GL, Tomassetti, S, Cavazza, A, et al. Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases. PLoS One, 9, 2014, e86716.
-
(2014)
PLoS One
, vol.9
, pp. e86716
-
-
Casoni, G.L.1
Tomassetti, S.2
Cavazza, A.3
-
66
-
-
84982170094
-
Cryobiopsy in the diagnosis of interstitial lung disease. A step forward or back?
-
66 Patel, NM, Borczuk, AC, Lederer, DJ, Cryobiopsy in the diagnosis of interstitial lung disease. A step forward or back?. Am J Respir Crit Care Med 193 (2016), 707–709.
-
(2016)
Am J Respir Crit Care Med
, vol.193
, pp. 707-709
-
-
Patel, N.M.1
Borczuk, A.C.2
Lederer, D.J.3
-
67
-
-
0037080547
-
American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias
-
67 American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165 (2002), 277–304.
-
(2002)
Am J Respir Crit Care Med
, vol.165
, pp. 277-304
-
-
-
68
-
-
5144222998
-
Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?
-
68 Flaherty, KR, King, TE Jr, Raghu, G, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?. Am J Respir Crit Care Med 170 (2004), 904–910.
-
(2004)
Am J Respir Crit Care Med
, vol.170
, pp. 904-910
-
-
Flaherty, K.R.1
King, T.E.2
Raghu, G.3
-
69
-
-
34248372493
-
Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis?
-
69 Flaherty, KR, Andrei, AC, King, TE Jr, et al. Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis?. Am J Respir Crit Care Med 175 (2007), 1054–1060.
-
(2007)
Am J Respir Crit Care Med
, vol.175
, pp. 1054-1060
-
-
Flaherty, K.R.1
Andrei, A.C.2
King, T.E.3
-
70
-
-
84981351583
-
Bronchoscopic lung cryobiopsy increases diagnostic confidence in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis
-
70 Tomassetti, S, Wells, AU, Costabel, U, et al. Bronchoscopic lung cryobiopsy increases diagnostic confidence in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 193 (2016), 745–752.
-
(2016)
Am J Respir Crit Care Med
, vol.193
, pp. 745-752
-
-
Tomassetti, S.1
Wells, A.U.2
Costabel, U.3
-
71
-
-
84951570581
-
Diagnostic certainty of idiopathic pulmonary fibrosis/usual interstitial pneumonia: the effect of the integrated clinico-radiological assessment
-
71 Tominaga, J, Sakai, F, Johkoh, T, et al. Diagnostic certainty of idiopathic pulmonary fibrosis/usual interstitial pneumonia: the effect of the integrated clinico-radiological assessment. Eur J Radiol 84 (2015), 2640–2645.
-
(2015)
Eur J Radiol
, vol.84
, pp. 2640-2645
-
-
Tominaga, J.1
Sakai, F.2
Johkoh, T.3
-
72
-
-
84901754507
-
Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines
-
72 Cottin, V, Crestani, B, Valeyre, D, et al. Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines. Eur Respir Rev 23 (2014), 193–214.
-
(2014)
Eur Respir Rev
, vol.23
, pp. 193-214
-
-
Cottin, V.1
Crestani, B.2
Valeyre, D.3
-
73
-
-
84900328026
-
Genetic determinants of pulmonary fibrosis: evolving concepts
-
73 Spagnolo, P, Grunewald, J, du Bois, RM, Genetic determinants of pulmonary fibrosis: evolving concepts. Lancet Respir Med 2 (2014), 416–428.
-
(2014)
Lancet Respir Med
, vol.2
, pp. 416-428
-
-
Spagnolo, P.1
Grunewald, J.2
du Bois, R.M.3
-
74
-
-
84897420090
-
Genetics and early detection in idiopathic pulmonary fibrosis
-
74 Putman, RK, Rosas, IO, Hunninghake, GM, Genetics and early detection in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 189 (2014), 770–778.
-
(2014)
Am J Respir Crit Care Med
, vol.189
, pp. 770-778
-
-
Putman, R.K.1
Rosas, I.O.2
Hunninghake, G.M.3
-
75
-
-
84901020197
-
Matrix biology of idiopathic pulmonary fibrosis: a workshop report of the national heart, lung, and blood institute
-
75 Thannickal, VJ, Henke, CA, Horowitz, JC, et al. Matrix biology of idiopathic pulmonary fibrosis: a workshop report of the national heart, lung, and blood institute. Am J Pathol 184 (2014), 1643–1651.
-
(2014)
Am J Pathol
, vol.184
, pp. 1643-1651
-
-
Thannickal, V.J.1
Henke, C.A.2
Horowitz, J.C.3
-
76
-
-
84908611170
-
Fibrosis: ultimate and proximate causes
-
76 Thannickal, VJ, Zhou, Y, Gaggar, A, Duncan, SR, Fibrosis: ultimate and proximate causes. J Clin Invest 124 (2014), 4673–4677.
-
(2014)
J Clin Invest
, vol.124
, pp. 4673-4677
-
-
Thannickal, V.J.1
Zhou, Y.2
Gaggar, A.3
Duncan, S.R.4
-
77
-
-
84908388851
-
Molecular biomarkers in idiopathic pulmonary fibrosis
-
77 Ley, B, Brown, KK, Collard, HR, Molecular biomarkers in idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 307 (2014), L681–L691.
-
(2014)
Am J Physiol Lung Cell Mol Physiol
, vol.307
, pp. L681-L691
-
-
Ley, B.1
Brown, K.K.2
Collard, H.R.3
-
78
-
-
43249084804
-
MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis
-
78 Rosas, IO, Richards, TJ, Konishi, K, et al. MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med, 5, 2008, e93.
-
(2008)
PLoS Med
, vol.5
, pp. e93
-
-
Rosas, I.O.1
Richards, T.J.2
Konishi, K.3
-
79
-
-
84922948913
-
Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease
-
79 Kropski, JA, Pritchett, JM, Zoz, DF, et al. Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease. Am J Respir Crit Care Med 191 (2015), 417–426.
-
(2015)
Am J Respir Crit Care Med
, vol.191
, pp. 417-426
-
-
Kropski, J.A.1
Pritchett, J.M.2
Zoz, D.F.3
-
80
-
-
84930865108
-
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study
-
80 Jenkins, RG, Simpson, JK, Saini, G, et al. Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study. Lancet Respir Med 3 (2015), 462–472.
-
(2015)
Lancet Respir Med
, vol.3
, pp. 462-472
-
-
Jenkins, R.G.1
Simpson, J.K.2
Saini, G.3
-
81
-
-
84866723961
-
Serological investigation of the collagen degradation profile of patients with chronic obstructive pulmonary disease or idiopathic pulmonary fibrosis
-
81 Leeming, DJ, Sand, JM, Nielsen, MJ, et al. Serological investigation of the collagen degradation profile of patients with chronic obstructive pulmonary disease or idiopathic pulmonary fibrosis. Biomark Insights 7 (2012), 119–126.
-
(2012)
Biomark Insights
, vol.7
, pp. 119-126
-
-
Leeming, D.J.1
Sand, J.M.2
Nielsen, M.J.3
-
82
-
-
84858427847
-
Peripheral blood biomarkers in idiopathic pulmonary fibrosis
-
82 Vij, R, Noth, I, Peripheral blood biomarkers in idiopathic pulmonary fibrosis. Transl Res 159 (2012), 218–227.
-
(2012)
Transl Res
, vol.159
, pp. 218-227
-
-
Vij, R.1
Noth, I.2
-
83
-
-
84998814253
-
Plasma surfactant protein-D, matrix metalloproteinase-7, and osteopontin index distinguishes idiopathic pulmonary fibrosis from other idiopathic interstitial pneumonias
-
published online May 5.
-
83 White, ES, Xia, M, Murray, S, et al. Plasma surfactant protein-D, matrix metalloproteinase-7, and osteopontin index distinguishes idiopathic pulmonary fibrosis from other idiopathic interstitial pneumonias. Am J Respir Crit Care Med, 2016, 10.1164/rccm.201505-0862OC published online May 5.
-
(2016)
Am J Respir Crit Care Med
-
-
White, E.S.1
Xia, M.2
Murray, S.3
-
84
-
-
84925086698
-
Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression
-
84 Yang, G, Yang, L, Wang, W, Wang, J, Wang, J, Xu, Z, Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression. Gene 562 (2015), 138–144.
-
(2015)
Gene
, vol.562
, pp. 138-144
-
-
Yang, G.1
Yang, L.2
Wang, W.3
Wang, J.4
Wang, J.5
Xu, Z.6
-
85
-
-
84862677507
-
The peripheral blood transcriptome identifies the presence and extent of disease in idiopathic pulmonary fibrosis
-
85 Yang, IV, Luna, LG, Cotter, J, et al. The peripheral blood transcriptome identifies the presence and extent of disease in idiopathic pulmonary fibrosis. PLoS One, 7, 2012, e37708.
-
(2012)
PLoS One
, vol.7
, pp. e37708
-
-
Yang, I.V.1
Luna, L.G.2
Cotter, J.3
-
86
-
-
84857922118
-
S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis
-
86 Hara, A, Sakamoto, N, Ishimatsu, Y, et al. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis. Respir Med 106 (2012), 571–580.
-
(2012)
Respir Med
, vol.106
, pp. 571-580
-
-
Hara, A.1
Sakamoto, N.2
Ishimatsu, Y.3
-
87
-
-
84883053337
-
CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases
-
87 Cai, M, Bonella, F, He, X, et al. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases. Respir Med 107 (2013), 1444–1452.
-
(2013)
Respir Med
, vol.107
, pp. 1444-1452
-
-
Cai, M.1
Bonella, F.2
He, X.3
-
88
-
-
84922227403
-
A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis
-
88 Bauer, Y, Tedrow, J, de Bernard, S, et al. A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 52 (2015), 217–231.
-
(2015)
Am J Respir Cell Mol Biol
, vol.52
, pp. 217-231
-
-
Bauer, Y.1
Tedrow, J.2
de Bernard, S.3
-
89
-
-
80053472343
-
Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle
-
89 Meltzer, EB, Barry, WT, D'Amico, TA, et al. Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle. BMC Med Genomics, 4, 2011, 70.
-
(2011)
BMC Med Genomics
, vol.4
, pp. 70
-
-
Meltzer, E.B.1
Barry, W.T.2
D'Amico, T.A.3
-
90
-
-
31944436620
-
Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis
-
90 Selman, M, Pardo, A, Barrera, L, et al. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med 173 (2006), 188–198.
-
(2006)
Am J Respir Crit Care Med
, vol.173
, pp. 188-198
-
-
Selman, M.1
Pardo, A.2
Barrera, L.3
-
91
-
-
84919768376
-
Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis
-
91 DePianto, DJ, Chandriani, S, Abbas, AR, et al. Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis. Thorax 70 (2015), 48–56.
-
(2015)
Thorax
, vol.70
, pp. 48-56
-
-
DePianto, D.J.1
Chandriani, S.2
Abbas, A.R.3
-
92
-
-
84881157502
-
Fibrosing interstitial lung disease. A practical high-resolution computed tomography-based approach to diagnosis and management and a review of the literature
-
92 Hodnett, PA, Naidich, DP, Fibrosing interstitial lung disease. A practical high-resolution computed tomography-based approach to diagnosis and management and a review of the literature. Am J Respir Crit Care Med 188 (2013), 141–149.
-
(2013)
Am J Respir Crit Care Med
, vol.188
, pp. 141-149
-
-
Hodnett, P.A.1
Naidich, D.P.2
-
93
-
-
84901759236
-
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis
-
93 King, TE Jr, Bradford, WZ, Castro-Bernardini, S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 370 (2014), 2083–2092.
-
(2014)
N Engl J Med
, vol.370
, pp. 2083-2092
-
-
King, T.E.1
Bradford, W.Z.2
Castro-Bernardini, S.3
|